Representative Byron Donalds Stocks
On February 11, 2025, Representative Byron Donalds of US Congress acquired under $15k worth of Merck Company's common stock. Such disclosures are part of transparency measures that require elected officials to report their investments, ensuring public awareness and preventing conflicts of interest. Below are 3 other transactions of Byron Donalds.| 2025-02-11 | Acquired Under $15K | MRK Merck Company | InsidersVerify |
| 2024-11-08 | Acquired Under $15K | APPF Appfolio | InsidersVerify |
| 2024-11-07 | Acquired Under $15K | SNPS Synopsys | InsidersVerify |
Risk-return Landscape of Byron Donalds's positions
Expected Return |
| Risk |
Assets Rated by Market Efficiency
Many investors optimize their portfolios to maintain a risk-return balance that meets their personal investing preferences and liquidity needs. Understanding the relationship between the Sharpe ratio, risk, and expected return will help you build an optimal portfolio from your selected positions. Below are the essential efficiency ratios that can help you quickly create a reliable input to your portfolio optimization process.
| Efficiency | Market Risk | Exp Return | Price |
|---|
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Recommendations on macroaxis.com are based on what is currently trending. Macroaxis LLC is not a registered investment advisor or broker/dealer.
The information on the site should be used for informational purposes only and is not investment advice.
more